Lead Product(s) : Silver Fluoride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase II/ Phase III
Sponsor : SDI Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth
Details : Silver Fluoride is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Dentin Sensitivity.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 18, 2021
Lead Product(s) : Silver Fluoride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase II/ Phase III
Sponsor : SDI Limited
Deal Size : Inapplicable
Deal Type : Inapplicable